BMP4 induced cyclin B1 and cyclin-dependent kinase 1 (CDK1) expression in HCC cells, thereby promoting cell cycle progression from G2 to M and resisting the oxaliplatin-derived G2/M blockade. The gene discussed is BMP4; the disease is hepatocellular carcinoma.